HCA Healthcare (NYSE:HCA) Upgraded at Baird R W

Baird R W upgraded shares of HCA Healthcare (NYSE:HCAFree Report) to a strong-buy rating in a research report sent to investors on Thursday morning, Zacks.com reports.

A number of other research analysts also recently issued reports on the stock. Oppenheimer boosted their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an outperform rating in a research report on Monday, April 29th. JPMorgan Chase & Co. upped their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a neutral rating in a report on Thursday. Cantor Fitzgerald restated an overweight rating and issued a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a report on Monday, April 29th. Finally, Raymond James increased their price objective on shares of HCA Healthcare from $300.00 to $330.00 and gave the company an outperform rating in a research note on Wednesday, January 31st. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of Moderate Buy and a consensus price target of $325.59.

Read Our Latest Stock Report on HCA

HCA Healthcare Trading Up 1.4 %

Shares of HCA Healthcare stock opened at $339.75 on Thursday. The firm has a market capitalization of $88.99 billion, a PE ratio of 16.94, a price-to-earnings-growth ratio of 1.56 and a beta of 1.66. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The firm’s 50 day moving average is $318.75 and its 200 day moving average is $308.35. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $339.97.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. During the same period in the previous year, the firm posted $4.93 EPS. The firm’s revenue was up 11.2% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare will post 20.84 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now owns 1,576 shares of the company’s stock, valued at $520,474. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at approximately $520,474. The disclosure for this sale can be found here. Insiders sold 13,617 shares of company stock valued at $4,321,986 over the last quarter. 1.60% of the stock is owned by company insiders.

Institutional Trading of HCA Healthcare

Several hedge funds have recently bought and sold shares of the stock. Jump Financial LLC lifted its position in shares of HCA Healthcare by 885.1% in the third quarter. Jump Financial LLC now owns 7,280 shares of the company’s stock valued at $1,791,000 after acquiring an additional 6,541 shares in the last quarter. Great Lakes Advisors LLC raised its position in HCA Healthcare by 143.4% during the third quarter. Great Lakes Advisors LLC now owns 11,763 shares of the company’s stock valued at $2,894,000 after purchasing an additional 6,931 shares during the period. Avantax Advisory Services Inc. raised its position in HCA Healthcare by 33.4% during the third quarter. Avantax Advisory Services Inc. now owns 4,305 shares of the company’s stock valued at $1,059,000 after purchasing an additional 1,079 shares during the period. Western Wealth Management LLC grew its stake in shares of HCA Healthcare by 2.5% during the third quarter. Western Wealth Management LLC now owns 3,394 shares of the company’s stock valued at $835,000 after buying an additional 83 shares during the last quarter. Finally, Fidelis Capital Partners LLC grew its stake in shares of HCA Healthcare by 17.5% during the third quarter. Fidelis Capital Partners LLC now owns 2,003 shares of the company’s stock valued at $493,000 after buying an additional 299 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.